Practical approaches to the management of autosomal dominant polycystic kidney disease patients in the era of tolvaptan.

These cases provide a discussion for the use of tolvaptan in ADPKD within the nephrology clinic and allow insights into the practicalities of using this therapy outside of clinical trials.